You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tau PET Scan

Showing 26 - 50 of 9,994
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Glioma, Recurrent Brain Tumor Trial in Rochester (procedure, drug, other)

Active, not recruiting
  • Malignant Glioma
  • Recurrent Brain Neoplasm
  • Biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 5, 2023

Ganglioneuroblastoma, Ganglioneuroma, Metastatic Neuroblastoma Trial in Rochester (Computed Tomography, Gallium Ga 68-DOTATATE,

Recruiting
  • Ganglioneuroblastoma
  • +2 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Parkinson Disease Trial in New Haven ([18F] PI-2620)

Recruiting
  • Parkinson Disease
  • [18F] PI-2620
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Sep 27, 2021

Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)

Recruiting
  • Breast Cancer
  • +5 more
  • 89Zr-DFO*-trastuzumab PET scan
  • Amsterdam, Noord-Holland, Netherlands
    AmsterdamUMC
Jul 12, 2023

F 18 T807 PETScan for HIV Infected & Uninfected

Completed
  • Alzheimer Disease
  • HIV
  • F 18 T807
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 17, 2020

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in New York (PET Scan)

Recruiting
  • Pancreatic Cancer
  • Pancreatic Ductal Adenocarcinoma
  • PET Scan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 16, 2022

Alzheimer, Cognitive Decline Trial in Dallas ([18F]AV-1451, Positron Emission Tomography)

Completed
  • Alzheimer Disease
  • Cognitive Decline
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 28, 2022

Meningioma Trial in Houston (Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography)

Recruiting
  • Meningioma
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 28, 2022

Mild Cognitive Impairment, Healthy, Alzheimer Trial in Schlieren (18F-AV-1451 (Tau-PET tracer))

Active, not recruiting
  • Mild Cognitive Impairment
  • +3 more
  • 18F-AV-1451 (Tau-PET tracer)
  • Schlieren, Zurich, Switzerland
    Institute for Regenerative Medicine (IREM)
Dec 21, 2021

Lung Non-Small Cell Carcinoma, Malignant Solid Tumor, Melanoma Trial in Duarte (procedure, other, radiation)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Apr 13, 2023

Arterial Stiffness Trial in Vandoeuvre les Nancy cedex (Measure of aortic inflammation)

Completed
  • Arterial Stiffness
  • Measure of aortic inflammation
  • Vandoeuvre les Nancy cedex, France
    CHRU Nancy
Nov 28, 2023

Patients With Metastatic Castration-resistant Prostate Cancer Trial (177Lu-PSMA-617 PET scan)

Not yet recruiting
  • Patients With Metastatic Castration-resistant Prostate Cancer
  • 177Lu-PSMA-617 PET scan
  • (no location specified)
Nov 13, 2023

Tau PET Imaging and CSF Biomarkers of AD in Humans

Active, not recruiting
  • Alzheimer Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 16, 2022

Pancreatic Cancer, Cholangiocarcinoma Trial in Amsterdam ([68Ga]Ga-FAPI-46 PET/CT)

Recruiting
  • Pancreatic Cancer
  • Cholangiocarcinoma
  • [68Ga]Ga-FAPI-46 PET/CT
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC, location VUmc
Jul 13, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 20, 2023

Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Chicago (procedure,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Biopsy of Prostate
  • +6 more
  • Chicago, Illinois
    Northwestern University
May 9, 2023

Lung Adenocarcinoma Trial in Los Angeles (drug, procedure, other)

Recruiting
  • Lung Adenocarcinoma
  • Los Angeles, California
    Yesenia Calzada
Jan 27, 2023

Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte (procedure, other, device)

Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm
  • Computed Tomography
  • +3 more
  • Duarte, California
    City of Hope Medical Center
May 3, 2023

Macrophage PET/CT Imaging Using 64Cu-DOTATATE for Diagnosis of

Recruiting
  • Cardiac Sarcoidosis
  • 64Cu-DOTATATE PET/CT scan
  • Copenhagen, Denmark
    Rigshospitalet
Nov 14, 2023

Regional Cerebral Protein Synthesis in Alzheimer's

Terminated
  • Alzheimer Disease
  • [C11] Leucine PET scan
  • +2 more
  • Manchester, United Kingdom
  • +1 more
Aug 5, 2022

PET/CT Imaging Trial in Columbus (PET/CT scan with 13 mCi radiation dose, PET/CT scan with 5 mCi radiation dose, PET/CT scan

Recruiting
  • PET/CT Imaging
  • PET/CT scan with 13 mCi radiation dose
  • +4 more
  • Columbus, Ohio
    The Ohio State University Wexner Medical Center
Apr 15, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • San Francisco, California
    University of California San Francisco
Dec 19, 2022

Rectal Cancer Trial (Chemoradiation treatment, 18FDG-PET/MRI scan)

Not yet recruiting
  • Rectal Cancer
  • Chemoradiation treatment
  • 18FDG-PET/MRI scan
  • (no location specified)
Sep 26, 2023

Prostate Cancer, Localized Prostate Carcinoma Trial (PSMA-1007 Positron Emission Tomography (PET) scan)

Not yet recruiting
  • Prostate Cancer
  • Localized Prostate Carcinoma
  • PSMA-1007 Positron Emission Tomography (PET) scan
  • (no location specified)
Aug 14, 2023

Advanced Cancers Trial in Houston (PET Scan, FLT)

Active, not recruiting
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022